Market Closed

CHRS
Coherus Oncology
$ 0.5255
-2.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Coherus Oncology News

Latest Coherus Oncology Stock News & CHRS Headlines

Down 49.7% in 4 Weeks, Here's Why Coherus Oncology (CHRS) Looks Ripe for a Turnaround
2 days ago | zacks.com
Coherus Oncology: 3 Key Takeaways for Long-Term Investors
5 days ago | fool.com
Coherus Oncology, Inc. (CHRS) Q3 2026 Earnings Call Transcript
5 days ago | seekingalpha.com
What Coherus Oncology (CHRS) Said on Its Q3 Earnings Call
5 days ago | marketbeat.com
Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates
5 days ago | zacks.com
Coherus Oncology Reports Third Quarter 2026 Financial Results and Announces Strategic Prioritization Plan
5 days ago | globenewswire.com
Will Coherus Oncology (CHRS) Report Negative Earnings Next Week? What You Should Know
13 days ago | zacks.com
Coherus Oncology, Inc. (CHRS) Discusses Tagmokitug Interim Clinical Data in Esophageal Cancer Transcript
17 days ago | seekingalpha.com
Coherus Oncology Reports 89% Response Rate in Early ESCC Study
17 days ago | marketbeat.com
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
17 days ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CHRS
Coherus Oncology
$ 0.5255
-2.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago